Chord Therapeutics
ExitedChord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.
Total raised
€14M
€13,626,480
Funding rounds
1
Investors
1
distinct backers
Active since
2020-10
latest 2020-10
Funding by year
EUR raised per yearFunding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-13 | Series A | €14M | Omega Funds | View deal → |
Exit
Type
acquisition
Date
Dec 2021
Value
—
Acquiror
Merck (United States of America)
Investors
1Related news
- Merck Buys Chord Therapeuticsfinsmes.com · 2021-12
- finsmes.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy